In a rabbit model we investigated the efficacy of a silk fibroin/hydroxyapatite (SF/HA) composite on the repair of a segmental bone defect. Four types of porous SF/HA composites (SF/HA-1, SF/HA-2, SF/HA-3, SF/HA-4) with different material ratios, pore sizes, porosity and additives were implanted subcutaneously into Sprague-Dawley rats to observe biodegradation. SF/HA-3, which had characteristics more suitable for a bone substitite based on strength and resorption was selected as a scaffold and co-cultured with rabbit bone-marrow stromal cells (BMSCs). A segmental bone defect was created in the rabbit radius. The animals were randomised into group 1 (SF/HA-3 combined with BMSCs implanted into the bone defect), group 2 (SF/HA implanted alone) and group 3 (nothing implanted). They were killed at four, eight and 12 weeks for visual, radiological and histological study.
In a rabbit model we investigated the efficacy of a silk fibroin/hydroxyapatite (SF/HA) composite on the repair of a segmental bone defect. Four types of porous SF/HA composites (SF/HA-1, SF/HA-2, SF/HA-3, SF/HA-4) with different material ratios, pore sizes, porosity and additives were implanted subcutaneously into Sprague-Dawley rats to observe biodegradation. SF/HA-3, which had characteristics more suitable for a bone substitite based on strength and resorption was selected as a scaffold and co-cultured with rabbit bone-marrow stromal cells (BMSCs). A segmental bone defect was created in the rabbit radius. The animals were randomised into group 1 (SF/HA-3 combined with BMSCs implanted into the bone defect), group 2 (SF/HA implanted alone) and group 3 (nothing implanted). They were killed at four, eight and 12 weeks for visual, radiological and histological study.
The bone defects had complete union for group 1 and partial union in group 2, 12 weeks after operation. There was no formation of new bone in group 3. We conclude that SF/HA-3 combined with BMSCs supports bone healing and offers potential as a bone-graft substitute.
Although bone has the capacity for regenerative growth and remodelling, these processes are often impaired in clinical situations in which loss of bone is caused by disease, trauma or tumour resection. It has been estimated that more than 800 000 bone grafts are performed annually worldwide. 1 Large bone defects represent a major problem in reconstructive surgery. Currently promotion of bone healing depends on autogenous and allogenic bone grafts, heterogeneous bone and synthetic materials. [2] [3] [4] Autologous bone grafting is the standard against which the repair of bone defects is judged. It provides the three elements necessary to generate and maintain bone, namely, an osteoconductive scaffold for bone ingrowth, osteoinductive growth factors and osteogenic progenitor cells. However, there are some disadvantages in this approach, including the extra incision required to obtain the graft, an increased operating time, the morbidity of the bone-graft incision donor site and infection. [5] [6] [7] Additionally, the amount of bone harvested may be insufficient. Allografts are generally available from tissue banks, but have the risk of transmission of disease and post-operative complications because of failure of vascularisation. 8, 9 New approaches include the use of conductive and inductive biomaterials containing bioactive molecules to promote cell migration and cell transplantation to the defect site in order to repair bone defects.
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The ideal scaffold should provide a suitable environment for tissue development. It should have good biocompatibility without any detrimental effects on surrounding tissues and favour the attachment of seeded cells and their growth and subsequent differentiation. It should also favour revascularisation, be osteoconductive, inductive, and osteointegrate with the host bone, have the potential to biodegrade while being gradually replaced by the newlyformed bone, be adaptable to an irregularlyshaped defect and support mechanical loading; and be storable and able to be sterilised without loss of properties. [14] [15] [16] However, a single material rarely has all of these prerequisites. The development of composite materials may offer a way forward. Silk fibroin extracted from a silkworm cocoon is an ideal biomaterial for medical application 17, 18 with studies showing that its toughness is better than that of collagen and that it can be used to reinforce inorganic materials. 19 We believe that silk fibroin/hydroxyapatite (SF/HA) as an artificial bone substitute may be applicable as a scaffold. We have therefore investigated the reconstruction of segmental bone defects in a rabbit model using an SF/HA composite combined with rabbit bone-marrow stromal cells (BMSCs) as implants for bone healing. Tables I and II . Sodium chloride was used as a porogen and short fibres were used to improve the resilience of the SF/ HA. Starch was used to speed up the degradation of SF/HA. These materials, after sterilisation by irradiation from a cobalt 60 source were implanted subcutaneously into the lumbar region of Sprague-Dawley rats so that their degradation and tissue reaction could be observed. The degradation was analysed macroscopically and histologically at two, six, 12, 16, 20 and 24 weeks after operation. Isolation and expansion of rabbit BMSCs. Using two-monthold New Zealand white rabbits BMSCs were isolated by density-gradient centrifugation from harvests of whole bone of approximately 5 ml obtained from the femoral condyle and tibial plateau. The adherent cells were allowed to reach approximately 80% confluence at about 14 days at passage 0. The cells were trypsinised and re-plated at a density of 5000 cells per cm 2 on 500 cm 2 triple flasks and cultured between seven and ten days or until they reached about 90% confluence. After trypsinisation, these cells were used to seed the scaffolds as described below. Scaffold selection and tissue culture. Based on the result of the degradation of SF/HA in vivo, SF/HA-3 was selected for the scaffold. For cultivation on the scaffold of SF/HA-3, which was 15 mm × 3 mm × 3 mm in size rabbit BMSCs of 90% confluence were suspended in liquid Dulbecco's modified Eagle's medium (DMEM; 5 × 10 7 cells per ml) and the suspension was seeded on to a pre-wetted scaffold (overnight incubation of scaffold in DMEM). The ordinary cell culture medium was prepared as follows: DMEM supplemented with 10% fetal bovine serum (FBS), 100 μ/ml of penicillin and Fungizone, 5.8 g/l of hydroxyethyl piperazine ethanesulfonic acid, 2 g/l of NaHCO 3 and 0.3 g/l of glutamine, with the pH adjusted from 7.2 to 7.4. The osteogenic medium was prepared as follows: the ordinary cell culture medium was supplemented with 50 gμ/ml of ascorbic acid-2-phosphate, 1 × 10 -8 g/l of dexamethasone and 10 mmol/l of β−glycerophosphate, Ascorbic acid-2-phosphate, dexamethasone and β−glycerophosphate were used as osteogenic inducing agents. The flasks were placed in a humidified incubator at 37°C and 5% CO 2 with the sidearm caps loosened to allow gas exchange. Half of the osteogenic medium was replaced every three days. Rabbit radial segmental bone defects. For the in vivo experiments we used 54 three-month-old New Zealand white rabbits, weighing between 2.0 kg and 2.5 kg. All the procedures were performed under a protocol approved by Soochow University Orthopaedics Centre Laboratory in accordance with the Guide for Care and Use of Laboratory Animals. 20 The rabbits were anaesthetised with an intramuscular injection of ketamine (1 ml/kg) into the buttocks and given lidocaine as a local anaesthesia. They maintained spontaneous breathing throughout. After they were shaved and the skin prepared in a standard fashion with antiseptic solution, one front leg of each rabbit was draped. A vertical skin incision 4 cm long was made over the middle of the anteromedial aspect of the radius and a 20 mm section of the radius with its periosteum was removed through an osteotomy. The scaffold was implanted into the defect which had been created without any gap between the material and the host bone. The diameter of the scaffold almost matched the diameter of the radius. The rabbits were randomly divided into three experimental groups. Group 1 was implanted with the tissue-engineered bone, group 2 with scaffold (SF/HA-3) alone and group 3 had no implants and were left with the defect unfilled.
Materials and Methods

Degradation
After the implantation of materials, the incision was closed with a 1-0 fiber thread suture line in a routine fash- ion. The rabbits were allowed to recover from the anaesthesia without restrictions. From each group six rabbits were killed at four, eight and 12 weeks after operation by injection of air under pentobarbital anaesthesia. Radiographs were obtained, a visual assessment was undertaken and histological examination was performed. Radiological evaluation. Anteroposterior (AP) and lateral views of the operated radius were checked every four weeks to compare the serial changes of callus in the bone-defect site and the time of formation of cortical bone and the medullary cavity. The formation of new bone in the defect was evaluated radiologically at four, eight, and 12 weeks after operation according to the Lane-Sandhu radiological score. 21 The score operates from three aspects. 1. The degree of bone formation (as an area of the total defects). 2. The degree of new bone connecting with host bone. 3. The amount of bone remodelling (with or without bone marrow cavity formation or cortical bone formation). Visual assessment. Healing of the defect was evaluated visually in all groups at four, eight and 12 weeks after operation. Histological assessment. A biopsy was obtained from the region of the excised radius and the adjacent normal bone from each rabbit. The resected radius was placed in 40% ethyl alcohol for two days. The samples were subsequently dehydrated by passing through increasing strengths of ethyl alcohol and were processed to produce undecalcified, plastic-embedded ground sections. The sections were then stained with haematoxylin and eosin and examined under light microscopy for characterisation of new bone and residual implant material in the defects. The formation of new bone in the defect was evaluated histologically at four, eight and 12 weeks after operation according to the LaneSandhu histological score.
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Bone strength test. From group 1 in which, on visual assessment, bone defects had repaired completely at 12 weeks, four radii were selected for the testing of bone strength. The contralateral normal radii were used as a control group. Bone strength was measured by a threepoint bending test. A 5 cm length of the bone segment including the area which had been replaced with the bone substitute was harvested. The test was undertaken using a Materials testing machine (MTS 858 Mini Bionix II; MTS, Albany, New York). Two supporting jigs were set on the instrument and the harvested bone segment was positioned. Each jig was placed 10 mm from the resected margin. The three-point bending test was performed with a cross-head speed of 1 mm/min with a 100 kg load cell. Statistical analysis. The radiological score, histological score and biomechanical data were statistically analysed by SAS version 8.0 software (SAS Institute Inc., Cary, North Carolina). The results are presented as the mean and SD. The radiological score of each group was compared using analysis of variance (ANOVA). The histological scores of group 1 and group 2 were compared using Student's t-test. The values of the bone-strength tests of the radius were compared with those of the contralateral normal radius using a paired sample t-test. A p-value of ≤ 0.05 was considered to be statistically significant.
Results
Degradation of SF/HA in vivo. HA, SF/HA-1 and SF/HA-2 showed little degradation within 24 weeks of the operation whereas SF/HA-3 had complete degradation in 12 to 16 weeks and SF/HA-4 within 12 weeks. Histological examination of tissue surrounding all four groups showed no evidence of apomorphosis and necrosis. There was no tissue growth in SF/HA-1 and SF/HA-2 while fibrous tissue and vascular tissue growth were identified in SF/HA-3 and SF/HA-4.
SF/HA-1 and SF/HA-2 were therefore considered to be unsuitable as a bone-tissue engineering scaffold because they were not degradable. SF/HA-4 was also considered to be unsuitable because its mean ability to resist pressure was 1.59 MPa (0.98 MPa to 1.87 MPa), which was insufficient for a scaffold. Therefore SF/HA-3 was selected as the scaffold. Rabbit radial segmental bone defects Radiological. In group 1, abundant callus was observed in the entire bone-defect site, which was connected to the bone fragment on both sides of the bone defect at four weeks. Cortical bone and the establishment of a medullary canal had partly appeared at eight weeks. Bone consolidation and formation of a medullary canal were clearly visible at 12 weeks (Fig. 1) .
In group 2, a small amount of callus had formed at the edges of the bone-defect site at four weeks. Comparatively, more callus had formed on both edges of the bone defect at eight weeks. The callus did not connect the bone fragments on both sides to the scaffold (SF/HA-3) which had nearly completely degraded at 12 weeks. The bone defect was partly repaired (Fig. 2) . In group 3, very little callus formed at the edge of the bone-defect site from four to 12 weeks (Fig. 3) .
There were significant differences in the radiological scores at four, eight and 12 weeks after operation in groups 1, 2 and 3 (Table III) . Bone formation was best in group 1 followed by group 2 and then group 3. Visual assessment. Ingroup 1, fibrocartilage was seen in the whole bone defect and had enveloped the tissueengineered bone at four weeks. Callus had formed at eight weeks. By 12 weeks, new bone remodelling was continuous and was the same as normal bone at 12 weeks (Fig. 4) .
In group 2, some fibrocartilage was seen at the edges of the bone defect at four weeks. Some callus had formed at the edges at eight weeks and the material had partly degraded. At 12 weeks, formation of new bone had occurred at the edges, but the bone defect had not repaired by the time the scaffold degraded (Fig. 5) . In group 3, there was no formation of new bone between four and 12 weeks (Fig. 6) . Histological. In group 1, abundant new cartilage and some woven bone were seen around the residual materials at four weeks. At eight weeks, more woven bone had formed, and ossification was identified. At 12 weeks cortical continuity and formation of the medullary cavity were seen in some parts of the woven bone.
In group 2, cartilage cells and some osteoblasts started to appear at the edge of the bone defect in the presence of residual material at four weeks. At eight weeks, some woven bone trabeculae were seen partly at the margin. At 12 weeks, more formation of new bone was seen at the edge of the defect, but with little residual scaffold material remaining. In group 3, histological examination was not carried out since there was no formation of new bone.
There were significant differences at four, eight and 12 weeks after operation in the histological scores of group 1 and group 2 (Table IV) . The results showed that the formation of bone in group 1 was better than that in group 2. in the control group. There was no statistical significance between them (t-test, p = 0.287).
Discussion
Hydroxyapatite is the major inorganic phase of bone to which host bone will form a direct bond. 22 However, it is not a perfect scaffold material for bone substitution because of its poor mechanical properties and minimal degradation in vivo. 23 Silk fibroin extracted from the cocoon is an ideal biomaterial for medical applications. It is non-toxic and non-polluting with good tissue compatibility and biodegradability. 24 The amino-acid composition of silk fibroin is similar to that of the keratin of skin and hair, with excellent physiochemical properties and good biocompatibility. 17 Silk fibroin can support the adhesion and proliferation of cells as can other biomaterials which are modified by silk fibroin. 18, 25 Additionally, the inflammatory response induced by silk fibroin is less marked compared with that of collagen although the ability to support cell adhesion, proliferation, differentiation and growth is the same. 26 Studies have shown that the toughness of silk fibroin is better than that of collagen and it can be used to reinforce inorganic materials. 19 In addition, compared with the commercially produced type-I collagen, silk fibroin is easy to extract, less expensive and is thus a promising tissue-engineering material. Bone scaffold needs a certain strength to maintain its shape during the formation of bone. However, the strength of silk fibroin is not sufficient for use as a bone scaffold alone. Thus, we incorporated hydroxyapatite in silk fibroin to improve its strength preparing an SF/HA porous composite material by isostatic pressing technology.
The degradation experiment showed that the four types of SF/HA which we produced had significantly different rates of degradation which seemed to depend on the size of the pore, porosity, the presence of starch and the proportions of HA and SF in the material. The degradation rate of SF/HA-1 and SF/HA-2 is similar to that of pure HA with almost no degradation within six months. The degradation rate of SF/HA-3 and SF/HA-4 was faster than that of SF/HA-1 and SF/HA-2 as a result of the porosity as well as the content of silk fibroin and the addition of starch. Previous studies have shown that pore size and porosity have significant effects on the degradation property of materials.
The greater the porosity is the faster the dissolution. 27 The pore increases the contact area between the material and tissue fluid, which faciliates biodegradation as well as the formation of new bone. 28, 29 Our study did not explore the biodegradation mechanism.
The ideal bone-graft substitute should be replaced completely by new bone. In bone-tissue engineering, the coordination between the biodegradation of material and the formation of bone is very important. Previous studies have shown that if the rate of degradation is too fast, the material will collapse, and compromise the repair, but if the rate is too slow, the formation of new bone, remodelling and reconstruction will be hindered. 30 The bone-graft substitute should be resorbed at a rate which balances the growth of new bone. 31 Ceramic substitutes such as hydroxyapatite may inhibit bone formation and weaken the intensity of newly-formed bone because they typically persist for longer than is required for the formation of new bone. SF/HA-3 degraded at a compatible rate and this was complete within 12 to 16 weeks, providing a scaffold for bone formation without hindering bone remodelling. With regard to biodegradation, both SF/HA-3 and SF/HA-4 are suitable bioscaffold materials, but SF/HA-4 is not able to maintain its shape because of its poor mechanical properties.
SF/HA-3 has an excellent three-dimensional porous structure, a high specific surface area and sufficient strength which created the conditions for the formation of new bone. Generally, a pore size of less than 100 μm can support the ingrowth of connective tissue, but is not favourable for osteocytic ingrowth. 32 Jones, Ahir and Hench 33 reported that satisfactory results were achieved by applying bioactive glass with a pore size greater than 100 μm as a tissueengineering scaffold. The mean pore size of SF/HA-3 was 120 μm (the greatest size is 345 μm) and the porosity was 80% which met the requirement for a bone-substitute material. The latter is another basic requirement of scaffold materials. It has been shown that new tissue can advance from the surface of a porous material into the inner part if the porosity is greater than 50% and the pores are interconnected. 34 The increase in porosity can improve the specific surface area and facilitate cell ingrowth, but decreases the mechanical strength of the material. The ideal bone-tissue engineering scaffold should have an appropriate porosity while still maintaining a certain shape. In our experiment, the mean mechanical strength of SF/HA-3 was 10.1 MPa when the porosity was up to 80%, which ensured the maintenance of the scaffold shape during bone formation and met the basic strength requirement of bone-tissue scaffold material. Therefore SF/HA-3 was chosen as the scaffold material. Our study showed that the tissue-engineered bone based on SF/HA-3 had a good proliferative effect with healing of a segmental bone defect of 20 mm within 12 weeks. It suggested that BMSCs continued to proliferate and differentiate in the scaffold after implantation without immune rejection, showing that SF/HA-2 had good cytocompatibility. The three-point bending test indicated that the strength of the regenerated zone was similar to that of normal bone.
In group 2, some repair of the defect did occur compared with group 3, but was incomplete. This suggested that SF/HA alone had no bone-inductive property, but did have some capacity for bone conduction. There was no obvious change except for the presence of fibrous tissue in the bone-defect zone in group 3, which suggested that the defect could not heal by itself.
In summary, the degradation rate and porosity of SF/HA varies with the content of silk fibroin, hydroxyapatite, additives and porogen. SF/HA-based tissue-engineered bone with a sufficient rate of degradation, pore size and porosity with added bone-marrow stromal cells could strike a balance between the formation of new bone and material absorption and form functional bone tissue within a short period, meeting the basic requisites of modern bonetissue engineering science. However, the SF/HA scaffold alone has no bone-inductive effect and the ability to repair a segmental bone defect by the application of SF/HA in isolation is limited.
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